The Enforcement Directorate on Friday arrested Bharat Rashtra Samiti leader K Kavitha after an hours-long raid at her premises in Hyderabad and brought her to Delhi for questioning in a money laundering case linked to the now-scrapped Delhi excise policy, agency sources said.
Drug shortages in the US are at an all-time high, and price erosion has stabilised, which could benefit Indian pharmaceutical (pharma) companies with a US focus, according to analysts. Nuvama Research analysts said that US price erosion seems to have normalised to its old levels of 6-8 per cent and volumes are picking up with easing of inventory. Similarly, an ICICIdirect analyst noted: "Price erosion intensity has now moderated to a single digit and is expected to tone down a
'Bharat is the core value that has to be lived by and if you deny it, then the people will discard you.'
Benoy Babu of Pernod Ricard and Sharath Reddy of Aurobindo Pharma have been arrested under sections of the PMLA.
India offers travel adventures no other country can offer.
Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a drug used to increase the production of natural tears in eyes. Similarly, Jubilant Cadista is recalling a drug which is used to treat different inflammatory conditions.
The victim, identified as Nargis, was attacked by a 28-year-old Irfan when she was with him in a park near Delhi University's Sri Aurobindo College, police said, adding, the accused has been arrested.
The Enforcement Directorate has summoned Telangana Chief Minister K Chandrashekar Rao's daughter K Kavitha in connection with a money laundering case linked to alleged irregularities in the Delhi excise policy, officials said on Wednesday.
Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.
The repair work was completed in 'record time' by workers of the Delhi Jal Board and the Public Works Department, they said.
An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India's pharmaceutical companies during the first quarter of this financial year, analysts said. Most brokerages estimate a top line growth of around 14-15 per cent, with earnings before interest, taxes, depreciation, and amortisation (Ebitda) growth of 24-30 per cent for Q1 of FY24. Hospitals are, however, likely to report lower occupancy rates, and diagnostics companies may witness an impact from delayed monsoon.
Kavitha Kalvakuntla, 44, a Bharat Rashtra Samiti MLC, declared this in a late-night post on her official Twitter handle.
Kavitha said 'these tactics of intimidation' against the fight of her father and Chief Minister K Chandrasekhar Rao and the BRS would not deter them.
Delhi deputy Chief Minister and AAP leader Manish Sisodia has been named as an accused in the case.
The agency made this disclosure on Monday before a local court in Delhi while seeking an extension of custody of Hyderabad-based businessman Arun Ramachandran Pillai, whom it had arrested on March 6.
Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past year with a return of over 30 per cent. The gains have come on the back of multiple triggers such as the scaling up of new product launches in the US market, clearance for its Moraiya (Gujarat) facility and steady performance in the domestic market. Though it has been the top pharma gainer in the 2022-23 financial year (FY23), brokerages continue to maintain their 'buy' stance, given the strong visibility in the US market.
The Supreme Court on Wednesday agreed to hear on March 24 a plea by K Kavitha, Bharat Rashtra Samithi leader and daughter of Telangana Chief Minister K Chandrasekhar Rao, seeking protection from arrest and challenging the summons by the Enforcement Directorate in a money laundering case arising out of the alleged Delhi excise policy scam.
The agency will question Sisodia on various aspects of the excise policy, his alleged links with liquor traders, and politicians and claims made by witnesses in their statements.
The Congress on Sunday took a strong exception to the exclusion of former prime minister Jawaharlal Nehru in the Karnataka government's newspaper advertisement on freedom fighters and termed the Bharatiya Janata Party action 'pathetic'.
Kavitha has asserted that she had done nothing wrong and alleged that the BJP-led Centre was "using" the ED as the saffron party could not gain a "backdoor entry" in Telangana.
West Bengal Chief Minister Mamata Banerjee on Thursday said she would not be attending the meeting convened by the Centre on December 24 to discuss ways to commemorate the birth anniversary of philosopher and revolutionary leader Rishi Aurobindo on August 15 next year, as part of the 75th Independence Day celebrations.
Sisodia said nothing was found against him during searches, and he would continue cooperating in the investigation.
Kavitha has spent around 18-19 hours at the ED headquarters in central Delhi during her two appearances on March 11 and March 20.
According to sources, Kavitha was to be made to sit face-to-face with Hyderabad-based businessman Arun Ramchandra Pillai, who was arrested in connection with the liquor policy case on Monday night.
The MLC daughter of Telangana Chief Minister K Chandrashekar Rao reached the ED office in central Delhi from the Tughlaq Road official residence of her father around 11.30 am and left shortly after 9.40 pm.
The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Outlining the wish list for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said the domestic pharma industry is currently around $50 billion in size and aspires to grow to around $130 billion by 2030 and $450 billion by 2047. "To achieve this vision, the Union Budget 2023-2024 should help fuel innovation and R&D, which will set the pace for propelling the pharmaceutical industry forward," he told PTI.
Bharat Rashtra Samiti leader K Kavitha on Thursday skipped the Enforcement Directorate (ED) summons here for questioning in the Delhi excise policy money laundering case and made a plea to defer the proceedings but it was rejected by the probe agency which asked her to appear on March 20.
Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid. Similarly, Aurobindo Pharma (USA) is recalling pain relieving drug, while Jubilant Cadista is recalling a medication used to treat schizophrenia.
Former Delhi deputy chief minister Manish Sisodia 'conspired' with others to frame a faulty excise policy in order to generate kickbacks and proceeds of crime to the tune of more than Rs 290 crore, the Enforcement Directorate (ED) alleged before a court in New Delhi on Friday.
The Enforcement Directorate on Friday claimed before a Delhi court that Aam Aadmi Party leader and former deputy chief minister Manish Sisodia was involved in "large scale destruction of digital evidence to impede investigation" into the Delhi excise policy case and had changed and destroyed 14 phones.
The announcement of Murmu's candidature by BJP president J P Nadda came a day after she celebrated her 64th birthday.
The CBI on Sunday deferred the questioning of Deputy Chief Minister Manish Sisodia in connection with the Delhi Excise policy scam case after he sought time from the probe agency citing the city government's ongoing budget exercise.
According to Outlook, Adani Group and the RP-Sanjeev Goenka Groups are no more the favourites to bag the new teams.
Manchester United owners showing interest to be a part of the Indian Premier League could be one of the reasons why BCCI extended the date for purchasing the Invitation to Tender (ITT) for the two new IPL teams.
Sisodia was arrested after nearly eight hours of questioning on various aspects of the excise policy for 2021-22, which the probe agency says suffered from irregularities both in its formulation and implementation, allegedly intended to benefit people with links to the AAP.
Ahmedabad-based Zydus Cadila, Bharat Biotech's intra-nasal candidate are among the candidates who got approval from the expert panel to conduct clinical trials, Sohini Das reports.
On July 21, the former Jharkhand governor Murmu registered a historic win over her rival Yashwant Sinha in the Presidential election, becoming the first woman tribal candidate and the second woman in the country to occupy the highest office in the country.
The Enforcement Directorate (ED) has arrested Aam Aadmi Party communication in-charge Vijay Nair and businessman Abhishek Boinpally in connection with its ongoing money laundering probe into the Delhi Excise policy that was scraped following corruption allegations, official sources said Monday.
The BCCI on Wednesday extended the deadline for purchasing the tender document for the new Indian Premier League teams by another 10 days till October 20.
A Delhi court on Friday sent former Delhi deputy chief minister Manish Sisodia, arrested in a money laundering case related to the excise policy, to the Enforcement Directorate's custody till March 17.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances